Recently, Ishiyama reported that olmesartan increased ACE2 expression in the remodeling heart after myocardial infarction, which theoretically could contribute to the beneficial effects of ARB by facilitating increased cardiac Ang-(1-7) formation [43]. This evidence concerns the gene ANG and myocardial infarction.